cbdMD (YCBD) Long-Term Investments (2017 - 2025)
cbdMD (YCBD) reported Long-Term Investments of $700000.0 for Q4 2025, little changed on a YoY basis from $700000.0 in Q4 2024, and little changed sequentially from $700000.0 in Q3 2025.
cbdMD (YCBD) Long-Term Investments (2017 - 2025) Analysis & Trends
cbdMD (YCBD) has 9 years of Long-Term Investments data on file, last reported at $700000.0 in Q4 2025.
- For the quarter ending Q4 2025, Long-Term Investments changed 0.0% year-over-year to $700000.0; the trailing twelve-month figure through Dec 2025 stood at $700000.0 (changed 0.0% YoY), and the FY2025 full-year result was $700000.0, changed 0.0% from the prior year.
- Long-Term Investments steadied at $700000.0 in Q4 2025, from $700000.0 in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $1.4 million in Q2 2022 to a low of $700000.0 in Q3 2023.
- A 5-year average of $947368.4 and a median of $700000.0 in 2023 frame the typical range for Long-Term Investments.
- Across the five-year window, Long-Term Investments jumped 300.0% in 2021 and slumped 50.0% in 2023, its largest moves.
- Tracing YCBD's Long-Term Investments over 5 years: stood at $1.0 million in 2021, then jumped by 40.0% to $1.4 million in 2022, then tumbled by 50.0% to $700000.0 in 2023, then changed by 0.0% to $700000.0 in 2024, then changed by 0.0% to $700000.0 in 2025.
- Business Quant data shows YCBD's Long-Term Investments at $700000.0 in Q4 2025, $700000.0 in Q3 2025, and $700000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.32 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 702.35 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | 700,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 700,000.00 |
| Sep 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Dec 31, 2024 | 700,000.00 |
| Sep 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 700,000.00 |
| Dec 31, 2023 | 700,000.00 |
| Sep 30, 2023 | 700,000.00 |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | 1.40 Mn |
| Sep 30, 2022 | 1.40 Mn |
| Jun 30, 2022 | 1.40 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Jun 30, 2021 | 1.00 Mn |
| Mar 31, 2021 | 1.00 Mn |
| Dec 31, 2020 | 250,000.00 |